Is it true that eliminating sugar starves cancer cells and shrinks tumors?

The claim that 'eliminating sugar starves cancer cells and shrinks tumors' oversimplifies and distorts what the science actually shows. While it is true that cancer cells have elevated glucose metabolism (the Warburg effect) and that glucose restriction can suppress primary tumor growth in some experimental contexts, the body does not simply 'starve' tumors when dietary sugar is reduced. The body tightly regulates blood glucose through gluconeogenesis — producing glucose from amino acids, glycerol, and lactate — meaning tumors continue to have access to glucose even on very low-carbohydrate or ketogenic diets. No robust clinical trial has demonstrated that sugar elimination reliably shrinks tumors in humans, and reviews of ketogenic diet use in oncology consistently describe clinical efficacy as 'unproven.'

Recent high-quality research has revealed a troubling paradox that directly undermines the simple 'starve the cancer' narrative: glucose restriction may simultaneously suppress primary tumor growth while promoting metastasis. A 2025 Cell study found that glucose deprivation, whether through low-carbohydrate diet or impaired in-situ metabolism, depletes natural killer (NK) cells in the lung via an exosomal TRAIL mechanism, creating a pre-metastatic niche that facilitates cancer spread. Clinically, low glucose metabolism correlated with higher postoperative recurrence across multiple cancer types. Additionally, glucose restriction can cause cancer cell dedifferentiation — pushing them toward a more aggressive, mesenchymal phenotype via HIF-1α activation — which may worsen outcomes.

Furthermore, glucose restriction impairs the function of the immune system's own anti-cancer defenses. T cells and CAR-T cells depend heavily on glucose for their effector functions; glucose-poor tumor microenvironments already hamper immune surveillance, and systemic dietary restriction could exacerbate this. The emerging picture is one of a 'double-edged sword': targeting glucose metabolism has genuine mechanistic rationale but produces complex, sometimes counterproductive effects in the whole-organism context. Simple dietary sugar elimination as a cancer treatment or adjunct therapy is not supported by clinical evidence and may carry real risks.